Recent research has unveiled that issues related to the sense of smell may emerge long before the clinical symptoms of Alzheimer's disease manifest. This phenomenon is linked to the activity of immune cells in the brain, known as microglia, which begin to dismantle connections between the olfactory bulb and the locus coeruleus. The olfactory bulb, situated in the forebrain, plays a crucial role in processing scent signals from the nose, while the locus coeruleus, located in the brainstem, helps manage various physiological functions including sensory processing.
Dr. Lars Paeger from DZNE and LMU explains, "The locus coeruleus influences numerous physiological mechanisms such as blood flow, sleep-wake cycles, and sensory processing, particularly concerning smell." His study indicates that in the early stages of Alzheimer's, alterations in the nerve fibers connecting these two regions signal to microglia that certain fibers are either damaged or unnecessary, prompting their breakdown.
Changes in Membrane Composition
The research team, led by Dr. Paeger alongside co-author Prof. Dr. Jochen Herms, discovered specific alterations in the membranes of the nerve fibers. They observed that phosphatidylserine, a fatty molecule typically found within a neuron's membrane, had migrated to the outer membrane surface. "The presence of phosphatidylserine externally acts as a signal for microglia to engage in synaptic pruning, which eliminates redundant or malfunctioning neuronal connections," notes Paeger. He suggests that this shift in membrane composition may be driven by hyperactive neurons due to Alzheimer's, leading to abnormal firing patterns.
Support from Diverse Research Evidence
The study's conclusions are bolstered by comprehensive evidence, including examinations of mice exhibiting Alzheimer-like symptoms, brain tissue samples from deceased patients, and positron emission tomography (PET) scans of individuals with Alzheimer's or mild cognitive impairment.
Joachim Herms, a research group leader at DZNE and LMU, emphasizes, "While the correlation between smell dysfunction and Alzheimer's has been acknowledged, the underlying causes remained elusive until now. Our findings highlight an immunological mechanism that triggers these dysfunctions at the disease's early stages."
Potential for Early Detection and Treatment
Recent advancements in amyloid-beta antibody treatments for Alzheimer's emphasize the importance of early intervention. The new insights from this research could significantly enhance early identification of individuals at risk, allowing for thorough testing and timely treatment before cognitive decline occurs. "This could facilitate earlier administration of amyloid-beta antibodies, increasing the likelihood of a favorable treatment response," concludes Herms.
